Literature DB >> 24179009

Adipokines protecting CKD.

Satoshi Miyamoto1, Kumar Sharma.   

Abstract

Increasing incidence of chronic kidney disease (CKD) which leads to end-stage renal disease (ESRD) is one of the major health issues in the modern world and requires novel strategies for treatment. Adipose tissue has been recognized to have endocrine function and secretes a variety of hormones called adipokines. Several adipokines have been implicated in the pathogenesis of CKD and may have a strong impact as a risk factor for renal decline. The aim of this review is to provide an overview of the role of adipokines in the progression of CKD, with focus on recent experimental and clinical advances.

Entities:  

Keywords:  AMPK; CKD; USF-1; adipokine; adiponectin

Mesh：

Substances：

Year:  2013        PMID： 24179009      PMCID： PMC3814228          DOI： 10.1093/ndt/gft261

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


  77 in total

1.  TNFalpha up-regulates apelin expression in human and mouse adipose tissue.

Authors:  Danièle Daviaud; Jérémie Boucher; Stéphane Gesta; Cédric Dray; Charlotte Guigne; Didier Quilliot; Ahmet Ayav; Olivier Ziegler; Christian Carpene; Jean-Sébastien Saulnier-Blache; Philippe Valet; Isabelle Castan-Laurell
Journal:  FASEB J       Date:  2006-05-24       Impact factor: 5.191

2.  Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway.

Authors:  Raogo Ouedraogo; Xiangdong Wu; Shi-Qiong Xu; Lauren Fuchsel; Hiroyuki Motoshima; Kalyankar Mahadev; Kelly Hough; Rosario Scalia; Barry J Goldstein
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

3.  Adiponectin and renal function, and implication as a risk of cardiovascular disease.

Authors:  Yoshio Iwashima; Takeshi Horio; Masahiro Kumada; Yoshihiko Suzuki; Shinji Kihara; Hiromi Rakugi; Yuhei Kawano; Tohru Funahashi; Toshio Ogihara
Journal:  Am J Cardiol       Date:  2006-10-18       Impact factor: 2.778

4.  Adiponectin and mortality in patients with chronic kidney disease.

Authors:  Vandana Menon; Lijun Li; Xuelei Wang; Tom Greene; Vaidyanathapuram Balakrishnan; Magdalena Madero; Arema A Pereira; Gerald J Beck; John W Kusek; Allan J Collins; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

5.  Omentin plasma levels and gene expression are decreased in obesity.

Authors:  Celia M de Souza Batista; Rong-Ze Yang; Mi-Jeong Lee; Nicole M Glynn; Dao-Zhan Yu; Jessica Pray; Kelechi Ndubuizu; Susheel Patil; Alan Schwartz; Mark Kligman; Susan K Fried; Da-Wei Gong; Alan R Shuldiner; Toni I Pollin; John C McLenithan
Journal:  Diabetes       Date:  2007-02-28       Impact factor: 9.461

6.  Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.

Authors:  Rong-Ze Yang; Mi-Jeong Lee; Hong Hu; Jessica Pray; Hai-Bin Wu; Barbara C Hansen; Alan R Shuldiner; Susan K Fried; John C McLenithan; Da-Wei Gong
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-03-10       Impact factor: 4.310

7.  Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study.

Authors:  Wing-Sun Chow; Bernard M Y Cheung; Annette W K Tso; Aimin Xu; Nelson M S Wat; Carol H Y Fong; Liza H Y Ong; Sidney Tam; Kathryn C B Tan; Edward D Janus; Tai-Hing Lam; Karen S L Lam
Journal:  Hypertension       Date:  2007-04-23       Impact factor: 10.190

8.  The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients.

Authors:  Yuichiro Yano; Satoshi Hoshide; Joji Ishikawa; Chishio Noguchi; Daisuke Tukui; Hidaka Takanori; Masashi Tada; Yoshimasa Kanemaru; Ayako Yano; Shizukiyo Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal:  Am J Hypertens       Date:  2007-05       Impact factor: 2.689

9.  Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study.

Authors:  B Kollerits; D Fliser; I M Heid; E Ritz; F Kronenberg
Journal:  Kidney Int       Date:  2007-04-25       Impact factor: 10.612

10.  Apelin and cardiac function in hemodialyzed patients: possible relations?

Authors:  Jolanta Małyszko; Jacek S Małyszko; Piotr Koźminski; Michał Myśliwiec
Journal:  Am J Nephrol       Date:  2006-03-17       Impact factor: 3.754
View more
  9 in total

1.  Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice.

Authors:  Mi Tian; Li Tang; Yuanyuan Wu; Srinivasan Beddhu; Yufeng Huang
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-06

Review 2.  The metabolic syndrome and chronic kidney disease.

Authors:  Xin Zhang; Lilach O Lerman
Journal:  Transl Res       Date:  2016-12-09       Impact factor: 7.012

3.  Survival Prediction in Patients with Hypertensive Chronic Kidney Disease in Intensive Care Unit: A Retrospective Analysis Based on the MIMIC-III Database.

Authors:  Zuoxun Xia; Peng Xu; Ye Xiong; Yunbo Lai; Zhaohui Huang
Journal:  J Immunol Res       Date:  2022-05-12       Impact factor: 4.493

Review 4.  Adipocytokines in renal transplant recipients.

Authors:  Kristof Nagy; Shankar Prasad Nagaraju; Connie M Rhee; Zoltan Mathe; Miklos Z Molnar
Journal:  Clin Kidney J       Date:  2016-03-15

5.  Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator.

Authors:  Satoshi Miyamoto; Cheng-Chih Hsu; Gregory Hamm; Manjula Darshi; Maggie Diamond-Stanic; Anne-Emilie Declèves; Larkin Slater; Subramaniam Pennathur; Jonathan Stauber; Pieter C Dorrestein; Kumar Sharma
Journal:  EBioMedicine       Date:  2016-03-28       Impact factor: 8.143

Review 6.  Nanotechnology advances towards development of targeted-treatment for obesity.

Authors:  Nicole Remaliah Samantha Sibuyi; Koena Leah Moabelo; Mervin Meyer; Martin Opiyo Onani; Admire Dube; Abram Madimabe Madiehe
Journal:  J Nanobiotechnology       Date:  2019-12-16       Impact factor: 10.435

7.  Astragalus membranaceus and Salvia miltiorrhiza Ameliorate Hypertensive Renal Damage through lncRNA-mRNA Coexpression Network.

Authors:  Le Zhou; Cong Han; Yao Liu; Tao Cui; Zhen Shen; Xiang-Yu Li; Yue-Hua Jiang; Wei Li
Journal:  Biomed Res Int       Date:  2022-09-09       Impact factor: 3.246

Review 8.  The complex effects of adipokines in the patients with kidney disease.

Authors:  Sahar Vahdat
Journal:  J Res Med Sci       Date:  2018-07-26       Impact factor: 1.852

Review 9.  Adiponectin in renal fibrosis.

Authors:  Huan Jing; Simin Tang; Sen Lin; Meijuan Liao; Hongtao Chen; Youling Fan; Jun Zhou
Journal:  Aging (Albany NY)       Date:  2020-02-17       Impact factor: 5.682
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.